0.4% Lidocaine Hydrochloride & 5% Dextrose Injection: Solution bags may be leaking in affected lots. (Updated with new lot numbers)
Last updated
Summary
Product
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection
Issue
Health products - Packaging
What to do
Consult your health care professional if you have any health concerns.
Distribution
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Baxter |
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection |
DIN 00828602 |
Solution |
DEXTROSE 50 MG / ML |
W3B01C1X |
Issue
Solution bags may be leaking in affected lots.
What you should do
- Verify if your product is affected.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Previous recalls or alerts
Background
Depth of recall: Wholesalers, Retailers, Healthcare establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
BAXTER CORPORATION
7125 Mississauga Road, Mississauga
Ontario Canada L5N 0C2
Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Recall class
Type I
Identification number
RA-73983
Get notified
Receive notifications for new and updated recalls and alerts by category.